Select Page
EPHA Joins Call for Public Return on Public Investment: Ensuring sustainable societal impact of EU-funded Biomedical Research and Innovation

EPHA Joins Call for Public Return on Public Investment: Ensuring sustainable societal impact of EU-funded Biomedical Research and Innovation

Civil society’s proposal for Horizon Europe, the next EU research framework programme High prices of new drugs for cancer, hepatitis C and rare diseases in Europe have attracted great media and public attention and have brought the debate about access to medicines...
Promising developments? – latest updates on access to affordable medicines

Promising developments? – latest updates on access to affordable medicines

What a busy week, last week has been for pharmaceutical policy-making in Europe! The Mediterranean initiative launched last July in Athens proves to be still alive with the signing of the Valletta Declaration last week in Malta by the Health Ministers of Portugal,...
Made with love by COCREATE